Privacy Analytics > Resources > Webinars > Safely Accelerate Clinical Document Submissions While Protecting Commercially Confidential Information (CCI)
Safely Accelerate Clinical Document Submissions While Protecting Commercially Confidential Information (CCI)
As a clinical trial sponsor, you’re under tight timelines to balance participant privacy and data utility in clinical document submissions while justifying and protecting commercially sensitive information.
To help with this, Privacy Analytics offers a complete, end-to-end solution for your clinical document submissions.
You’ll ensure your competitive edge by meeting deadlines for initiatives such as EU CTR, Health Canada PRCI, and EMA Policy 0070 while protecting participant privacy and identifying and protecting commercially confidential information (CCI).
Join Niamh McGuinness, Senior Advisor, Clinical Trial Transparency and Privacy, to find out which combination of our flexible solutions best meets your needs:
As a clinical trial sponsor, you’re under tight timelines to balance participant privacy and data utility in clinical document submissions while justifying and protecting commercially sensitive information.
To help with this, Privacy Analytics offers a complete, end-to-end solution for your clinical document submissions.
You’ll ensure your competitive edge by meeting deadlines for initiatives such as EU CTR, Health Canada PRCI, and EMA Policy 0070 while protecting participant privacy and identifying and protecting commercially confidential information (CCI).
Join Niamh McGuinness, Senior Advisor, Clinical Trial Transparency and Privacy, to find out which combination of our flexible solutions best meets your needs:
Niamh McGuinness is an expert in clinical trial document submissions and a senior member of the Privacy Analytics team, focused on Clinical Trial Transparency (CTT). She has personally managed many successful projects, with documents representing hundreds of clinical trials. Under her watch, no client has ever missed a regulatory submission deadline or a deadline to make their trial data publicly available.
Niamh’s team works with a variety of clinical trial sponsors that have turned to Privacy Analytics to meet the stringent requirements of regulations such as EMA Policy 0070, Health Canada Public Release of Clinical Information (PRCI), and EU CTR.
Niamh McGuinness, PhD
Director, Clinical Trial Transparency